New Findings from Inha University in Pancreatic Cancer Provides New Insights (Vactosertib, Tgf-beta Receptor I Inhibitor, Augments the Sensitization of the Anti-cancer Activity of Gemcitabine In Pancreatic Cancer)

Press/Media

Period22 Jun 2023

Media coverage

1

Media coverage